Ergoteles’s Strongbridge Biopharma plc. SBBP Stock Holding History

Ergoteles’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-153,518	Closed	-$313K	–	1794
2021 Q3	$313K	Sell	153,518 -941,899	-86%	-$2.19M	0.01%	780
2021 Q2	$3.25M	Buy	+1,095,417	New	+$2.89M	0.07%	297

Ergoteles's SBBP Position: Q4 2021 in Review

Ergoteles sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 153,518 shares — an estimated $313K sold.

Ergoteles first reported a position in SBBP in Q2 2021 and held it in 2 quarters. The position peaked at $3.25M in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

Ergoteles reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 153,518 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $313K.
Ergoteles first reported a position in Strongbridge Biopharma plc. in Q2 2021 and held it in 2 quarters.
Ergoteles's Strongbridge Biopharma plc. position peaked at $3.25M in Q2 2021.
0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.